Deferasirox
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1425 publications
Apparent plateaus during iron chelation in transfusion-dependent β-thalassemia: interpretation and clinical implications.
Journal: Expert review of hematology
Published: May 07, 2026
Comparative Study of Ferritin Levels between Two Generic Formulations of Deferasirox in Sri Lankan Patients with Beta-Thalassemia Major.
Journal: Hemoglobin
Published: April 07, 2026
Successful Outcome of Rhino-Orbital-Cerebral Mucormycosis With Extensive Intracranial Disease in a Patient With Poorly Controlled Diabetes.
Journal: The Permanente journal
Published: March 23, 2026
Triple Iron Chelation in Transfusion Dependent Thalassemia: A Case Report.
Journal: Journal of clinical medicine
Published: March 13, 2026
Management of Iron Overload in Infants and Toddlers With Diamond-Blackfan Anemia Syndrome: A French-Italian Study.
Journal: American journal of hematology
Published: March 10, 2026
Combination of Deferoxamine and Deferiprone demonstrates superior efficiency compared to monotherapies in management of cardiac iron overload: Evidence from meta-analysis.
Journal: European journal of pharmacology
Published: February 26, 2026
Environmental heat exposure triggers neuronal apoptosis via NCOA4-mediated ferritinophagy.
Journal: Environment international
Published: February 22, 2026
Safety and Efficacy of Iron Chelators in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis
Published: February 22, 2026
Transfusion-Related Iron Overload in Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Addressing an Overlooked Treatment Complication.
Journal: Cureus
Published: February 09, 2026
Mitochondria-targeted carbon monoxide delivery combined with iron chelation therapy for cancer synergistic treatment.
Journal: Colloids and surfaces. B, Biointerfaces
Published: February 05, 2026
Evaluation of Active and Passive Targeting Drug Delivery Systems as a Mechanism to Improve the Anticancer Potential of Titanium(IV).
Journal: ChemMedChem
Published: January 30, 2026
Last Updated: 06/30/2026